Navigation Links
Duragesic Trials Continue - Plaintiffs Optimistic After Latest Recall
Date:2/13/2008

Lawyer who brought the first federal case against J&J prepares for next

trial

LOS ANGELES, Feb. 13 /PRNewswire/ -- In the wake of Tuesday's Duragesic recall of over 2 million patches, lawyer Ike Gulas prepares to take the next major case against pharmaceutical giant Johnson and Johnson to trial in California State Court Southeast District in Los Angeles.

The Birmingham, Ala.-based law firm Gulas & Stuckey PC took the first Duragesic case to federal trial in West Palm Beach in June 2007, winning a $5.5 million verdict for the family of Adam Hendelson who died from an overdose of the drug fentanyl when the patch he wore due to chronic hip pain leaked.

The family of Carol Pinedo will be the second of Gulas & Stuckey's clients to face Johnson & Johnson subsidiaries Janssen Pharmaceutica Products, LP, and ALZA Corp. in court over death resulting from the company's pain patch Duragesic.

Pinedo died in April 2004, the same month Janssen issued a recall of about 2.2 million patches after determining that some might leak along one edge. She was 39 at the time and had been wearing a Duragesic patch for 6 months as treatment for severe migraines following the removal of benign brain tumors.

Pinedo's husband Joseph, has brought the suit forward to Gulas & Stuckey after his wife's death. Joseph is a custodian for the Los Angeles school system with four children: Jessie Marie, Michelle, Christine and Natalie Angela.

"The manufacturers of this drug should be held accountable," said Ike Gulas. "This recent recall reaffirms the fact that this drug is lethal and is responsible for many unnecessary deaths, as in the case of Carol Pinedo."

More than 100 cases have been filed nationwide involving Duragesic. Gulas & Stuckey will take the Pinedo case to trial sometime later this year.

For more information about Duragesic and about Gulas & Stuckey, P.C., go to http://www.gulasandstuckey.com/PracticeAreas/duragesic.asp.


'/>"/>
SOURCE Gulas & Stuckey, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
2. Study Questions Dead-End Cancer Clinical Trials
3. Clinical trials present better alternatives for dialysis patients
4. IMPACT initiative looks to improve patient participation in clinical trials
5. Clinical Trials Directive still hampering academic medical research
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
8. Clinical Trials for Lupus Underway After Decades of Drought
9. Paving the way for future pan-European clinical trials
10. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
11. Rutgers biomaterial debuts in clinical trials of new stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the leading ... Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” http://www.beckersspine.com/spine-leaders/item/35348- ... in Michigan performing minimally invasive back surgery that often results in less post-operative ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important ... February 23, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , If you want to find out what really happened in the ...
(Date:2/22/2017)... ... , ... BrightStar Care Charleston , a home care and medical staffing ... (MUSC) Center on Aging’s Senior Expo on Thursday, March 23, 2017, at the ... resource in our community. We are thrilled to participate in this event because we ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... pipeline and the number of African American/Black students who want to become physicians. ... to pursue their careers as physicians in the Oakland/San Francisco Northern California, Bay ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017 Kineta, Inc., a biotechnology ... immune modulating therapies, today announced that KCP-400 (RgIA4), ... receptor (nAChR), demonstrates robust chronic pain relief and ... study also establishes the a9a10 nAChR as a ... pain. The findings were reported online in the ...
(Date:2/22/2017)... and HAMBURG, Germany , February 22, 2017 ... precision oncology headquartered in Hamburg, Germany and ... research institution, announced today a collaboration to support the first Indian ... research. ... Indivumed signed an agreement with an initial three-year term. The collaboration ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 ... equipment with specialized versions are used to monitor physiological ... or as remote patient monitors. Remote patient monitoring is ... of the patient monitoring equipment in the market. Hence, ... integrated with smartphones and applications, which can send test ...
Breaking Medicine Technology: